AbbVie reports positive data for Rinvoq in psoriatic arthritis
AbbVie discovered and developed Rinvoq to treat immune-mediated inflammatory diseases. Credit: AbbVie Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
